Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Management
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Latest news

Group By Ticker
Sort By
Newest | Oldest
Read More
31 minute read
  • Options

Stocks That Hit 52-Week Lows On Wednesday

By Benzinga Insights
Today, 8:20 AM
  On Wednesday, 479 stocks made new 52-week lows.

AAP

Read More
31 minute read
  • Options

Stocks That Hit 52-Week Lows On Friday

By Benzinga Insights
Today, 8:20 AM
  On Friday, 497 companies set new 52-week lows.

AADI

Read More
2 minute read
  • Intraday Update
  • Markets
  • News

A Look Into Invitae’s Debt

By Benzinga Insights
Today, 8:20 AM
Over the past three months, shares of Invitae Inc. (NYSE:NVTA) decreased by 31.61%. When understanding a companies price…

NVTA

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target

Piper Sandler Maintains Underweight on Invitae, Lowers Price Target to $1.75

By Benzinga Newsdesk
Today, 8:20 AM
Piper Sandler analyst David Westenberg maintains Invitae (NYSE:NVTA) with a Underweight and lowers the price target from $2.25 to $1.75.

NVTA

Read More
1 minute read
  • Earnings
  • Guidance
  • Movers
  • News
  • Penny Stocks
  • Small Cap
  • Trading Ideas

Why Invitae Corporation Shares Are Falling Today

By Sean Torres
Today, 8:20 AM
Invitae Corporation (NYSE: NVTA) shares are trading lower this Wednesday after the company reported fourth-quarter financial results and provided guidance for full-year 2023. The company also announced that it has signed exchange and financing agreements with a fund managed by Deerfield Management C

NVTA

Read More
3 minute read
  • Intraday Update
  • Markets
  • Movers
  • News
  • Penny Stocks
  • Small Cap
  • Trading Ideas

Why Novavax Shares Are Trading Lower By Around 28%? Here Are Other Stocks Moving In Wednesday’s Mid-Day Session

By Lisa Levin
Today, 8:20 AM
Gainers Reata Pharmaceuticals Inc (NASDAQ: RETA) shares jumped 171.5% to $84.67 after the company reported the FDA approval of SKYCLARYS for patients with Friedreich's Ataxia.

ADMP

Read More
1 minute read
  • Guidance
  • News

Invitae Is Expecting 2023 Revenue To Be Over $500M With A Non-GAAP Gross Margin Of 48-50%, And Cash Burn Of $250-275M, Representing A Significant Improvement From 2022

By Happy Mohamed
Today, 8:20 AM
Financial Guidance On a pro forma basis, the company exited fourth quarter 2022 at an annualized revenue of approximately $450 million for its remaining business. Management is expecting 2023

NVTA

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • Downgrades
  • Penny Stocks
  • Price Target
  • Small Cap
  • Top Stories

InVitae’s ‘Long, Uncertain Path’ Toward Profitability: Analyst Downgrades Biotech

By Priya Nigam
Today, 8:20 AM
Shares of Invitae Corp (NYSE: NVTA) came under pressure on Monday, after gaining more than 24% in January. Despite having a restricting plan in place, the biotech company has a “long path to profitability,” according to Goldman Sachs.

NVTA

Read More
1 minute read
  • Analyst Ratings
  • Downgrades
  • News
  • Price Target

Goldman Sachs Downgrades Invitae to Sell, Announces $2 Price Target

By Benzinga Newsdesk
Today, 8:20 AM
Goldman Sachs analyst Matthew Sykes downgrades Invitae (NYSE:NVTA) from Neutral to Sell and announces $2 price target.

NVTA

Read More
2 minute read
  • Intraday Update
  • Markets
  • News

Invitae’s Debt Overview

By Benzinga Insights
Today, 8:20 AM
Over the past three months, shares of Invitae Inc. (NYSE:NVTA) moved lower by 13.23%. Before having a look at the importance of debt, let's look at how much debt Invitae has.

NVTA

Posts navigation

1 2 … 16 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service